ADVFN US – Market Content Editor

Moderna (NASDAQ:MRNA) gained 3% on Thursday after presenting a new multi-year roadmap at its Analyst Day, detailing how it intends to expand its vaccine portfolio and accelerate progress in oncology. The biotech company said it is aiming for up to 10% revenue growth in 2026, supported by its seasonal vaccine franchise and a stronger late-stage…

ZKH Group Limited (NYSE:ZKH), a key player in China’s maintenance, repair, and operations (MRO) procurement sector, posted third-quarter results on Thursday that came in below Wall Street expectations. The stock slipped 0.33% in pre-market trading after the release. The company generated $319.43 million in revenue, well under the $363.54 million consensus forecast. Although ZKH recorded…

Jacobs Solutions Inc. (NYSE:J) delivered stronger-than-expected fiscal fourth-quarter results on Thursday, lifting its shares 1.6% in early trading after the release. The company reported adjusted EPS of $1.75, ahead of the $1.67 analysts were looking for. Revenue for the quarter ended September 26, 2025, came in at $3.2 billion, beating the $3.15 billion consensus estimate…

Wellgistics Health, Inc. (NASDAQ:WGRX) saw its stock decline 3.45% in pre-market trading on Thursday after the company reported a much larger third-quarter loss, driven primarily by a spike in stock-based compensation. The health IT firm posted a Q3 2025 net operating loss of $33.878 million, a dramatic widening from the $1.867 million loss recorded a…

Liquidity Services (NASDAQ:LQDT) delivered a stronger-than-anticipated fourth-quarter performance on Thursday, with broad-based growth pushing its annual Gross Merchandise Volume (GMV) above $1.5 billion for the first time. Shares of the company climbed 1.52% following the results. The online marketplace operator reported adjusted EPS of $0.37, comfortably ahead of the $0.31 analysts were expecting. Quarterly revenue…

Allot Ltd. (NASDAQ:ALLT) moved sharply higher in premarket trading on Thursday, rising 4.45% after the company delivered a stronger-than-expected third-quarter update powered by rapid growth in its Security-as-a-Service (SECaaS) business and a notable improvement in profitability. The company posted adjusted EPS of $0.10, far ahead of the $0.04 analysts were expecting. Revenue reached $26.4 million,…

Exact Sciences (NASDAQ:EXAS) extended its rally on Thursday, jumping another 17% after soaring 24% the previous day. The renewed surge came after Abbott (NYSE:ABT) formally confirmed it will acquire the cancer diagnostics specialist in a deal worth roughly $21 billion. In premarket trading, Exact Sciences shares traded around $101, following Wednesday’s close of $86.18, a…